Eli Lilly shares rise after $870 million protein deal expansion
Eli Lilly expanded a drug-discovery partnership with Gate Bioscience, with LLY shares up about 3.6% to $1,200.23 around 11.44am EST on Oct. 7, 2026.
23 on October 7, 2026. The target: proteins that have proved tough for conventional medicines to tackle. The valu…